Search by Drug Name or NDC

NDC 43063-0493-30 Lovastatin 10 mg/1 Details

Lovastatin 10 mg/1

Lovastatin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is LOVASTATIN.

MedlinePlus Drug Summary

Lovastatin is used together with diet, weight-loss, and exercise to reduce the risk of heart attack and stroke and to decrease the chance that heart surgery will be needed in people who have heart disease or who are at risk of developing heart disease. Lovastatin is also used to decrease the amount of cholesterol (a fat-like substance) and other fatty substances in the blood. Lovastatin is in a class of medications called HMG CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and, therefore, the oxygen supply to your heart, brain, and other parts of your body. Lowering your blood level of cholesterol and fats with lovastatin may help prevent heart disease, angina (chest pain), strokes, and heart attacks.

Related Packages: 43063-0493-30
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lovastatin

Product Information

NDC	43063-0493
Product ID	43063-493_05b7d6fb-daa0-4159-e063-6394a90a0ad8
Associated GPIs	39400050000305
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Lovastatin
Proprietary Name Suffix	n/a
Non-Proprietary Name	lovastatin
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	10
Active Ingredient Units	mg/1
Substance Name	LOVASTATIN
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA078296
Listing Certified Through	2024-12-31

Package

NDC 43063-0493-30 (43063049330)

Pricing Information	N/A
NDC Package Code	43063-493-30
Billing NDC	43063049330
Package	30 TABLET in 1 BOTTLE, PLASTIC (43063-493-30)
Marketing Start Date	2013-11-15
NDC Exclude Flag	N